Evaluation of mobilized CD34+ cell counts to guide timing and yield of large-scale collection by leukapheresis

Journal of Hematotherapy and Stem Cell Research

Volumn 7, Issue 1, 1998, Pages 45-52

  Knudsen, Lene Meldgaard ^a   Gaarsdal, Eva ^a   Jensen, Linda ^a   Nikolaisen, Kirsten ^a   Johnsen, Hans E ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BONE MARROW SUPPRESSION; BREAST CANCER; CANCER CHEMOTHERAPY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTIOCYTOSIS; HODGKIN DISEASE; HUMAN; LEUKAPHERESIS; LEUKEMIA; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD34; BLOOD SPECIMEN COLLECTION; CELL COUNT; EVALUATION STUDIES; FEMALE; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; LEUKAPHERESIS; LINEAR MODELS; MALE; MIDDLE AGED; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS;

EID: 0031946272     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.1.1998.7.45     Document Type: Review

References (14)

1. Henon, P.R., Liang, H., Beck-Wirth, G., et al. Comparison of hematopoietic and immune recovery after autologous bone marrow or blood stem cell transplants. Bone Marrow Transplant. 9:285, 1992.
2. Schwartzberg, L., Birch, R., Blanco, R., et al. Rapid and sustained hemopoietic reconstitution by peripheral blood stem cell infusion alone following high-dose chemotherapy. Bone Marrow Transplant. 11:369, 1993.
3. To, L.B., Roberts, M.M., Haylock, D.N., et al. Comparison of hematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. Bone Marrow Transplant. 9:277, 1992.
4. Knudsen, L.M., Gaarsdal, E., Jensen, L., et al. Improved priming for mobilization of and optimal timing for harvest of peripheral blood stem cells. J. Hematother. 5:399, 1996.
5. Bensinger, W.I., Longin, K., Appelbaum, F., et al. Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony-stimulating factor (rhG-CSF): An analysis of factors correlating with the tempo of engraftment after transplantation. Br. J. Haematol. 87:825, 1994.
6. Pettengell, R., Morgenstern, G.R., Wol, P.J., et al. Peripheral blood progenitor cell transplantation in lymphoma and leukemia using a single apheresis. Blood 82:3770, 1993.
7. To, L.B., Sheppard, K.M., Haylock, D.N., et al. Single high doses of cyclophosphamide enable the collection of high numbers of hemopoietic stem cells from the peripheral blood. Exp. Hematol. 18:442, 1990.
8. Johnsen, H.E. & Knudsen, L.M., for the Nordic Stem Cell Laboratory Group (NSCL-G). Nordic flow cytometry standards for CD344+ cell enumeration in blood and leukapheresis products: Report from the Second Nordic Workshop. J. Hematother. 5:237, 1996.
9. Siena, S., Bregni, M., Brando, B., et al. Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 77:400, 1991.
10. Bender, J.G., Williams, S.F., Myers, S., et al. Characterization of chemotherapy mobilized peripheral blood progenitor cells for use in autologous stem cells transplantation. Bone Marrow Transplant. 10:281, 1992.
11. Hohaus, S., Goldschmidt, H., Ehrhardt, R., et al. Successful autografting following myeloablative conditioning therapy with blood stem cells mobilized by chemotherapy plus rhG-CSF. Exp. Hematol. 21:508, 1993.
12. Bender, J.G., To, L.B., Williams, S., et al. Defining a therapeutic dose of peripheral blood progenitor cells. J. Hematother. 1:329, 1992.
13. Faucher, C., Le Corroller, A.G., Chabannon, C., et al. Autologous transplantation of blood stem cells mobilized with filgrastim alone in 93 patients with malignancies: The number of CD34+ cells reinfused is the only factor predicting both granulocyte and platelet recovery. J. Hematother. 5:663, 1996.
14. Schiller, G., Rosen, L., Vesico, R., et al. Threshold dose of autologous CD34-positive peripheral blood progenitor cells required for engraftment after myeloablative treatment for multiple myeloma. Blood 84 (Suppl.): 207 (abstract 813) 1994.